-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-09-21
A 2025 GeroScience study developed a drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibitors at substantially lower concentrations than a wild-type yeast background. The system identified activity from Torin1, omipalisib, AZD8055, and aminophylline while finding no evidence of TOR inhibition for several tested compounds, including Canagliflozin.
-
Gingerenone A Re-sensitizes RCC to Sunitinib
2026-09-21
The reference study identifies gingerenone A as a metabolic intervention that targets LDHA-driven glycolysis and restores sunitinib responsiveness in renal cell carcinoma models. Its combination of computational target discovery, metabolic rescue experiments, drug-combination analysis, and in vivo validation supports a mechanistic link between glycolytic suppression, HIF-1α signaling, and resistance reversal.
-
Linoleic Acid (C18:2) Protocol and QC Guide
2026-09-20
Linoleic Acid (SKU C3108) provides a defined C18:2(9Z,12Z) fatty acid input for oxidative stress, membrane, erythrocyte, migration, and nutritional deficiency workflows. It is water-insoluble, requires an ethanol- or DMSO-based preparation, and should be used freshly rather than from long-stored solutions.
-
AKT Inhibitors: Mechanisms, Resistance, and Combinations
2026-09-19
Kostaras and colleagues systematically compared ATP-competitive and allosteric AKT inhibitors using biochemical, cellular, structural, and phosphoproteomic approaches. Their findings show that inhibitor class, AKT isoform, mutation status, and non-catalytic signaling can strongly shape drug response, providing a framework for rational combination studies.
-
Pazopanib Hydrochloride: Smarter In Vitro Assays
2026-09-19
Build more informative oncology experiments with Pazopanib Hydrochloride by separating growth arrest from true cell killing. This workflow combines target-aware dosing, time-resolved viability measurements, and practical troubleshooting for renal cell carcinoma, soft tissue sarcoma, and angiogenesis models.
-
Alternariol and Liver Fibrosis: Study Insights
2026-09-18
The reference study shows that Alternariol (AOH) and alternariol monomethyl ether can drive LX-2 hepatic stellate cells toward a contractile, myofibroblast-like phenotype, whereas tenuazonic acid produced no significant response in the reported model. By combining lncRNA-mRNA omics with pathway analysis, the work connects Alternaria-toxin exposure with NF-κB activation, ferroptosis, and AMPK/AKT/mTOR-related autophagy, while also examining CotA laccase as a possible AOH detoxification strategy.
-
Coronavirus Macrodomain Counters PARP Antiviral Defense
2026-09-18
Grunewald et al. showed that coronavirus macrodomains protect viral replication by counteracting PARP-dependent restriction and interferon induction. Pharmacologic inhibition and PARP12/PARP14 depletion connected ADP-ribosylation with antiviral immunity, providing a mechanistic framework for studying coronavirus host–virus interactions.
-
Tunable Human Intestinal Organoids: Study Insights
2026-09-17
The reference study develops a human small-intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity under a unified culture condition. Its central advance is a tunable strategy that strengthens stem-cell potential first, then uses Wnt, Notch, BMP, and BET-related perturbations to bias differentiation in reversible or lineage-directed ways.
-
Acifran B6848 for Reliable Lipid Assays
2026-09-17
Learn how Acifran (SKU B6848) can be incorporated into receptor, lipid-signaling, viability, and cytotoxicity workflows without confusing pathway modulation with direct cell death. This scenario-based guide connects product handling with recent HCAR2/HCAR3 structural evidence and practical assay controls.
-
Cytoskeleton-Dependent Autophagy Under Mechanical Stress
2026-09-16
The reference study shows that compression-induced autophagy in human cells depends primarily on cytoskeletal microfilaments, while microtubules make an auxiliary contribution. Its intervention-based design links cellular mechanics to autophagosome responses and provides a useful framework for separating force transmission from downstream stress signaling.
-
Autophagy–Liver Metastasis Signature in CRC
2026-09-15
Bai et al. developed a six-gene prognostic signature that integrates autophagy and liver-metastasis biology in colorectal cancer using bulk and single-cell transcriptomic analyses. The model links higher risk with an immunosuppressive microenvironment, exhausted CD8+ T cells, SPP1+ M2-like macrophages, and possible resistance to immunotherapy, while also illustrating the limits of computational biomarker translation.
-
Biotin-tyramide for Reliable Cell Assay Imaging
2026-09-15
Learn how Biotin-tyramide (SKU A8011) can extend cell viability, proliferation, and cytotoxicity studies with spatially resolved endpoint labeling. This scenario-based guide covers mechanism, compatibility, solvent preparation, interpretation, and practical product-selection criteria for TSA workflows.
-
3D Organoid–Fibroblast Models of PDAC Resistance
2026-09-14
Schuth et al. developed a patient-specific three-dimensional co-culture system combining pancreatic ductal adenocarcinoma organoids with matched cancer-associated fibroblasts to model stromal effects on chemotherapy response. The study links fibroblast-mediated protection from drug-induced death with inflammatory fibroblast states and epithelial-to-mesenchymal transition-associated changes in tumor organoids, providing a framework for more physiologically relevant drug profiling.
-
Carbapenemase Transmission in CREC Hospitals
2026-09-14
Chen et al. (2025) mapped carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong during 2022–2024. The study combines gene localization, antimicrobial susceptibility testing, conjugation assays, mobile-element analysis, and strain typing to show that plasmid-associated blaNDM−1 and efficient horizontal transfer are central features of CREC dissemination.
-
Linoleic Acid C18:2 Workflow Guide
2026-09-13
Linoleic Acid (C18:2(9Z,12Z), SKU C3108) provides a defined omega-6 fatty acid input for studying lipid exposure, oxidative stress, membrane behavior, epithelial migration, and essential fatty acid biology. It is water-insoluble, requires a controlled ethanol or DMSO vehicle, and is best used with freshly prepared solutions rather than long-term aqueous or stored-stock workflows.